ResMed Inc Stock News

ResMed's (RMD) respiratory care business witnesses continued customer uptake of bilevel and other non-invasive ventilator solutions worldwide.

Investors continue to be optimistic about ResMed (RMD) backed by the continued demand for digital health solutions.

Medical equipment name ResMed Inc (NYSE:RMD) is looking to snap a four-day win streak, down 0.3% at $221.33 at last glance.

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs 4

Investors interested in stocks from the Medical - Products sector have probably already heard of Zimmer Biomet (ZBH) and ResMed (RMD). But which of these two stocks offers value investors a better ban

Sleep-apnea device maker ResMed broke out after earnings, continuing its accelerating growth pace. The post Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales Surge appeared first on

ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.

ResMed Inc. (RMD) Q3 2023 Earnings Call Transcript.

ResMed shares are selling on the expensive side of a fair value but the numbers and growth potential make us bullish on the stock. Fundamentals are strong and the forecast 6.3% annual market growth ma

SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on Thursday,

These mid-cap growth stocks could deliver market-beating returns in 2023 and beyond.

With the markets in flux, bargain hunters may have some prime opportunities to load up on quality names this week. Brown & Brown, Markel, and ResMed are three top-notch growth stocks worth considering

Investors are optimistic about ResMed's (RMD) Increased demand for its digital health solution.

Investors are optimistic about ResMed's (RMD) Increased demand for its digital health solution.

SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Scie